DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 083856
NDA 083856 describes ESTRATAB, which is a drug marketed by Solvay and is included in four NDAs. Additional details are available on the ESTRATAB profile page.
The generic ingredient in ESTRATAB is estrogens, esterified. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estrogens, esterified profile page.
The generic ingredient in ESTRATAB is estrogens, esterified. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estrogens, esterified profile page.
Summary for 083856
| Tradename: | ESTRATAB |
| Applicant: | Solvay |
| Ingredient: | estrogens, esterified |
| Patents: | 0 |
| Therapeutic Class: | Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1.25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
